1. Killing activity of human umbilical cord blood-derived TCRValpha24⁺ NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells

   • Masao Hagihara
   • Balgansuren Gansuvd
   • Tomomitsu Hotta

   Original Article Pages: 1 - 8

2. Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells

   • Michele Maio
   • Ester Fonsatti
   • Giorgio Parmiani

   Original Article Pages: 9 - 14

3. Binding to CD20 by Anti-B1 Antibody or F(ab')₂ is sufficient for induction of apoptosis in B-cell lines

   • Pina M. Cardarelli
   • Maire Quinn
   • Geoffrey Yarranton

   Original Article Pages: 15 - 24

4. Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells

   • Angela Märten
   • Tim Greten
   • Ingo G. Schmidt-Wolf

   Original Article Pages: 25 - 32

5. A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma

   • Shin-ichi Takemura
   • Toshio Kudo
   • Izumi Kumagai

   Original Article Pages: 33 - 44

6. Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial

   • Juan Hernando
   • Tjoung-Won Park
   • Thomas Bauknecht

   Original Article Pages: 45 - 52

7. The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation

   • Andy Huang
   • Helen Quinn
   • Timothy G. Allen-Mersh

   Short Communication Pages: 53 - 57

8. Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK

   • Robert C. Rees
   • Graham Pawelec
   • Adrian Robins

   Symposium Series Pages: 58 - 61